Bandingkan Harga & Kinerja Kalbe Farma Tbk (KLBF) vs Sarana Menara Nusantara Tbk. (TOWR)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Kalbe Farma Tbk dan Sarana Menara Nusantara Tbk.: Kalbe Farma Tbk diperdagangkan di Rp800 (kapitalisasi pasar 37,45 T, volume 24 jam 41,79 jt), sedangkan Sarana Menara Nusantara Tbk. diperdagangkan di Rp388 (kapitalisasi pasar 23,17 T, volume 24 jam 43,43 jt). Perbedaan utamanya: Kalbe Farma Tbk lebih besar dari sisi kapitalisasi pasar, dan Sarana Menara Nusantara Tbk. lebih aktif diperdagangkan (43,43 jt vs 41,79 jt). Mana yang lebih baik tergantung tujuan investasimu.
| KLBF | TOWR | |
|---|---|---|
Kapitalisasi Pasar | 37,45 T | 23,17 T |
Volume | 41,79 jt | 43,43 jt |
Lot | 417,89 rb | 434,3 rb |
Perputaran | 33,46 M | 16,85 M |
Harga Rata-rata | 800,79 | 387,95 |
Nilai Transaksi | 33,46 M | 16,85 M |
Harga Ekuilibrium Indikatif | 800 | 388 |
Volume Ekuilibrium Indikatif | 18,3 rb | 3,03 rb |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Kalbe Farma Tbk
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Selengkapnya di halaman KLBF →Tentang Sarana Menara Nusantara Tbk.
PT Sarana Menara Nusantara Tbk (the company) was established based on Deed of Establishment (Article of Association) No.31 dated June 2, 2008 drawn up in the presence of Dr. Irawan Soerodjo, S.H., MSi., Notary in Jakarta.The Company's articles of association has been amended several times, most recently by notarial deed No. 71 of Irawan Soerodjo, S.H., dated Nov 18, 2009, concerning among others, the change in par value, and public offering
Selengkapnya di halaman TOWR →
